MicroRNA-34a in triple negative breast cancer

miR-34a is a tumor supressor lowly expressed in triple negative breast cancer, and miR-34a replacement therapy has been suggested for patients with this disease. In this project we confirm that miR-34a is highly associated with regulation of the cell cycle, and we show that miR-34a expression is also associated with altered production of amino acids.

 

Participants:

Marie Engkvist Rosvold, Else Munthe, Thomas Fleischer

 
Page visits: 154